NATO-SFS, AB (COST, AVICENNE, EUREKA, FP6, FP7, vb.) UN, NSF,
UNDP, UNESCO, MED-CAMPUS, British Council vb. Uluslararası kurum ve
kuruluşlarca desteklenen projelerde görev almak
| Görevi |
Proje Adı |
Kurum |
Durum |
Baslama |
Bitiş |
| ARAŞTIRMACI |
CA 21169 - INFORMATION, CODING, AND BIOLOGICAL FUNCTION: THE DYNAMICS OF LIFE (DYNALIFE) |
|
DEVAM EDIYOR |
2022 |
|
| ARAŞTIRMACI |
CA 21116 - IDENTIFICATION OF BIOLOGICAL MARKERS FOR PREVENTION AND TRANSLATIONAL MEDICINE IN PANCREATIC CANCER (TRANSPAN) |
|
DEVAM EDIYOR |
2022 |
|
| ARAŞTIRMACI |
CA19133 - FOSTERING AND STRENGTHENING APPROACHES TO REDUCING COERCION IN EUROPEAN MENTAL HEALTH SERVICES (FOSTREN) |
|
DEVAM EDIYOR |
2020 |
|
| ARAŞTIRMACI |
CA20124 - MAXIMISING IMPACT OF MULTIDISCIPLINARY RESEARCH IN EARLY DIAGNOSIS OF NEONATAL BRAIN INJURY (AI-4-NICU) |
|
DEVAM EDIYOR |
2021 |
|
| ARAŞTIRMACI |
CA20122 - HARMONIZING CLINICAL CARE AND RESEARCH ON ADRENAL TUMOURS IN EUROPEAN COUNTRIES (HARMONISATION) |
|
DEVAM EDIYOR |
2021 |
|
| ARAŞTIRMACI |
CA19138 - LOBULAR BREAST CANCER: DISCOVERY SCIENCE, TRANSLATIONAL GOALS, CLINICAL IMPACT (LOBSTERPOT) |
|
DEVAM EDIYOR |
2020 |
|
| ARAŞTIRMACI |
CA20117 - CONVERTING MOLECULAR PROFILES OF MYELOID CELLS INTO BIOMARKERS FOR INFLAMMATION AND CANCER |
|
DEVAM EDIYOR |
2021 |
|
| ARAŞTIRMACI |
CA20121 - BENCH TO BEDSIDE TRANSITION FOR PHARMACOLOGICAL REGULATION OF NRF2 IN NONCOMMUNICABLE DISEASES |
|
DEVAM EDIYOR |
2021 |
|
| ARAŞTIRMACI |
CA18208 - NOVEL TOOLS FOR TEST EVALUATION AND DISEASE PREVALENCE ESTIMATION |
|
DEVAM EDIYOR |
2019 |
|
| ARAŞTIRMACI |
CA18218 - EUROPEAN BURDEN OF DISEASE NETWORK |
|
DEVAM EDIYOR |
2019 |
|
